US Patent Issued to Incyte on May 27 for "Imidazolyl pyrimidinylamine compounds as CDK2 inhibitors" (Delaware, Pennsylvania, Maryland, New Jersey Inventors)

ALEXANDRIA, Va., June 17 -- United States Patent no. 12,312,331, issued on May 27, was assigned to Incyte Corp. (Wilmington, Del.).

"Imidazolyl pyrimidinylamine compounds as CDK2 inhibitors" was invented by Qinda Ye (Claymont, Del.), Jingwei Li (Westfield, N.J.), Ken Mukai (Wilmington, Del.), Brandon Smith (Chadds Ford, Pa.), Liangxing Wu (Wilmington, Del.), Wenqing Yao (Chadds Ford, Pa.), Min Ye (Garnet Valley, Pa.), Yingnan Chen (Wilmington, Del.), Margaret Favata (North East, Md.) and Yvonne Lo (Hockessin, Del.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application provides imidazolyl pyrimidinylamine inhibitors of cyclin-dependent kinase 2 (CDK2), as well as pharmaceutical compositions th...